REVERSE BRIGHTENING DEFENSE FLUID- avobenzone, homosalate, octocrylene, octisalate lotion 
Rodan & Fields

----------

Drug Facts

Active Ingredients

Avobenzone 2.8%,

Homosalate 9.3%,

Octisalate 4.67%,

Octocrylene 6.1%

Purpose

Sunscreen

Uses

Warnings

For external use only.

Do not use on

  • damaged or broken skin.

When using this product

  • keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

  • rash occurs.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

protection measures including:

Inactive Ingredients

Adenosine, Aminomethyl Propanol, Aqua/Eau/Water, Benzyl Alcohol, Butylene Glycol, C12-15 Alkyl Benzoate, Calcium Gluconate, Citral, Citric Acid, Cynara Scolymus (Artichoke) Leaf Extract, Dimethicone, Dimethicone/Vinyl Dime­thicone Crosspolymer, Dipotassium Glycyrrhizate, Fragrance/Parfum, Glucono­lactone, Glycerin, Glycine Soja (Soybean) Oil, Hydrogenated Lecithin, Limonene, Linalool, Methyl Carboxymethylphenyl Aminocarboxypropylphosphonate, Phenoxyethanol, Propanediol, Rosmarinic Acid, Rutin, Sesamum Indicum (Sesame) Seed Extract, Silica, Sodium Benzoate, Sodium Carbomer, Titanium Dioxide (Cl 77891), Tocopherol, Xanthan Gum.

Other Information

Protect this product from excessive heat and direct sun.

Questions?

1-888-995-5656

Principal Display Panel - 30 mL Carton Label

RODAN+FIELDS

REVERSE

Brightening Defense
Fluid Lotion

Broad Spectrum SPF 50

3AM

30 mL/1. Fl. Oz. U.S.

Principal Display Panel - 30 mL Carton Label

Principal Display Panel - 30 mL Tube Label

RODAN+FIELDS

REVERSE

Brightening Defense Fluid Lotion

Broad Spectrum SPF 50

3AM

Principal Display Panel - 30 mL Tube Label
REVERSE BRIGHTENING DEFENSE FLUID 
avobenzone, homosalate, octocrylene, octisalate lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:14222-2300
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE0.028 g  in 1 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE0.093 g  in 1 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE0.061 g  in 1 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE0.0467 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ADENOSINE (UNII: K72T3FS567)  
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
CALCIUM GLUCONATE (UNII: SQE6VB453K)  
CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC)  
CITRAL (UNII: T7EU0O9VPP)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
CYNARA SCOLYMUS LEAF (UNII: B71UA545DE)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX)  
GLUCONOLACTONE (UNII: WQ29KQ9POT)  
GLYCERIN (UNII: PDC6A3C0OX)  
HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N)  
LIMONENE, (+)- (UNII: GFD7C86Q1W)  
LINALOOL, (+/-)- (UNII: D81QY6I88E)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
PROPANEDIOL (UNII: 5965N8W85T)  
ROSMARINIC ACID (UNII: MQE6XG29YI)  
RUTIN (UNII: 5G06TVY3R7)  
SESAME SEED (UNII: 7Y1255HVXR)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SOYBEAN OIL (UNII: 241ATL177A)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TOCOPHEROL (UNII: R0ZB2556P8)  
WATER (UNII: 059QF0KO0R)  
XANTHAN GUM (UNII: TTV12P4NEE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:14222-2300-11 in 1 CARTON03/09/2021
130 mL in 1 TUBE; Type 0: Not a Combination Product
2NDC:14222-2300-21 in 1 CARTON06/01/2021
27 mL in 1 TUBE; Type 0: Not a Combination Product
3NDC:14222-2300-32 mL in 1 PACKET; Type 0: Not a Combination Product04/12/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02003/09/2021
Labeler - Rodan & Fields (051659584)

Revised: 12/2023
Document Id: 0e1bd3b8-48f9-4e74-8685-d5ad2463a258
Set id: dc230e1e-bfb8-4d7c-bad5-bff77d78220e
Version: 3
Effective Time: 20231204
 
Rodan & Fields